-
1.发明公开POLYMORPHIC MARKER THAT CAN BE USED TO ASSESS THE EFFICACY OF INTERFERON THERAPY 有权多晶型标记，用来保证干扰素治疗的有效性DETERMINE
公开(公告)号：EP1436756A2
公开(公告)日：2004-07-14
申请号：EP02763042.5
申请日：2002-09-20
CPC分类号： C12Q1/6886 , C12Q2600/156
摘要： The present invention provides a polymorphic marker found in a region of the interferon receptor gene that can be used to assess the efficacy of interferon therapy. Thus, the present invention also relates to methods of assessing the efficacy of interferon therapy in an individual and means for accomplishing such a method.
-
2.发明授权POLYMORPHIC MARKER THAT CAN BE USED TO ASSESS THE EFFICACY OF INTERFERON THERAPY 有权多晶型标记，用来保证干扰素治疗的有效性DETERMINE
公开(公告)号：EP1436756B1
公开(公告)日：2009-01-07
申请号：EP02763042.5
申请日：2002-09-20
CPC分类号： C12Q1/6886 , C12Q2600/156
摘要： The present invention provides a polymorphic marker found in a region of the interferon receptor gene that can be used to assess the efficacy of interferon therapy. Thus, the present invention also relates to methods of assessing the efficacy of interferon therapy in an individual and means for accomplishing such a method.
-
搜索结果
2 条记录 (耗时 0.009 秒)
筛选
AND
AND
过滤
NOT
NOT
扫码加群
